Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0037 | 0.1185 | 0.378 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.1185 | 0.1158 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.1185 | 0.1158 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0059 | 0.2078 | 1 |
Schistosoma mansoni | polyomavirus enhancer activator 3 pea3 | 0.0012 | 0.018 | 0.0151 |
Echinococcus multilocularis | GA binding protein alpha chain | 0.0084 | 0.3084 | 1 |
Loa Loa (eye worm) | ets-domain-containing protein | 0.0012 | 0.018 | 0.0067 |
Echinococcus multilocularis | ETS transcription factor Elf 2 | 0.0012 | 0.018 | 0.0492 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0072 | 0.2603 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0117 | 0.4419 | 0.4355 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0059 | 0.2078 | 0.1986 |
Echinococcus granulosus | GA binding protein alpha chain | 0.0084 | 0.3084 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0013 | 0.0218 | 0.0188 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0072 | 0.2603 | 0.8423 |
Schistosoma mansoni | hypothetical protein | 0.0012 | 0.018 | 0.0151 |
Brugia malayi | transcription factor E74 isoform | 0.0012 | 0.018 | 0.0072 |
Echinococcus multilocularis | ets variant gene 4 | 0.0012 | 0.018 | 0.0492 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0037 | 0.1185 | 0.1088 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0072 | 0.2603 | 1 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0059 | 0.2078 | 0.6078 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0029 | 0.087 | 0.5 |
Schistosoma mansoni | cpg binding protein | 0.0036 | 0.1145 | 0.1118 |
Schistosoma mansoni | hypothetical protein | 0.0012 | 0.018 | 0.0151 |
Echinococcus multilocularis | Ataxin 2, N terminal,domain containing protein | 0.0013 | 0.0218 | 0.0615 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0037 | 0.1185 | 0.378 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0059 | 0.2078 | 0.6078 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.1185 | 0.1158 |
Loa Loa (eye worm) | tyrosyl-DNA phosphodiesterase | 0.0078 | 0.2857 | 0.2774 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0059 | 0.2078 | 0.697 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0059 | 0.2078 | 0.2054 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0059 | 0.2078 | 0.6078 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0117 | 0.4419 | 0.4355 |
Schistosoma mansoni | ets | 0.0012 | 0.018 | 0.0151 |
Echinococcus multilocularis | ETS transcription factor Elf 2 | 0.0012 | 0.018 | 0.0492 |
Brugia malayi | hypothetical protein | 0.0029 | 0.087 | 0.077 |
Echinococcus multilocularis | ETS transcription factor Elf 5 | 0.0012 | 0.018 | 0.0492 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0072 | 0.2603 | 0.8721 |
Echinococcus granulosus | ETS transcription factor Elf 2 | 0.0012 | 0.018 | 0.0492 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0059 | 0.2078 | 0.6078 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0059 | 0.2078 | 1 |
Echinococcus granulosus | ETS transcription factor Elf 2 | 0.0012 | 0.018 | 0.0492 |
Echinococcus granulosus | ETS transcription factor Elf 5 | 0.0012 | 0.018 | 0.0492 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0034 | 0.1066 | 0.0963 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0037 | 0.1185 | 0.378 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0451 | 0.0346 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.018 | 0.0067 |
Trypanosoma brucei | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0078 | 0.2857 | 1 |
Echinococcus multilocularis | ETS transcription factor Elf 1 | 0.0012 | 0.018 | 0.0492 |
Schistosoma mansoni | cpg binding protein | 0.0036 | 0.1145 | 0.1118 |
Loa Loa (eye worm) | DNA-binding protein D-ETS-3 | 0.0012 | 0.018 | 0.0067 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0114 | 0.0275 |
Loa Loa (eye worm) | D-ets-4 DNA binding domain-containing protein | 0.0012 | 0.018 | 0.0067 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0059 | 0.2078 | 0.6078 |
Schistosoma mansoni | elf1 | 0.0012 | 0.018 | 0.0151 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0072 | 0.2612 | 0.259 |
Brugia malayi | DNA-binding protein D-ETS-3 | 0.0012 | 0.018 | 0.0072 |
Brugia malayi | CXXC zinc finger family protein | 0.0034 | 0.1066 | 0.0968 |
Loa Loa (eye worm) | hypothetical protein | 0.0072 | 0.2592 | 0.2506 |
Brugia malayi | Tyrosyl-DNA phosphodiesterase family protein | 0.0078 | 0.2857 | 0.2778 |
Brugia malayi | Ets-domain containing protein | 0.0012 | 0.018 | 0.0072 |
Leishmania major | tyrosyl-DNA phosphodiesterase 1 | 0.0078 | 0.2857 | 1 |
Echinococcus multilocularis | GPCR, family 2 | 0.0037 | 0.1185 | 0.378 |
Echinococcus multilocularis | ETS domain containing protein Elk 1 | 0.0012 | 0.018 | 0.0492 |
Echinococcus granulosus | ETS transcription factor Elf 1 | 0.0012 | 0.018 | 0.0492 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0059 | 0.2078 | 0.6078 |
Echinococcus multilocularis | protein C ets 2 | 0.0012 | 0.018 | 0.0492 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0037 | 0.1185 | 0.1083 |
Brugia malayi | Ets-domain containing protein | 0.0084 | 0.3084 | 0.3008 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0059 | 0.2078 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0029 | 0.087 | 0.5 |
Echinococcus granulosus | Ataxin 2 N terminaldomain containing protein | 0.0013 | 0.0218 | 0.0615 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0059 | 0.2078 | 0.6704 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0059 | 0.2078 | 1 |
Echinococcus multilocularis | transcription factor Dp 1 | 0.0045 | 0.1522 | 0.4885 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0117 | 0.4419 | 0.4358 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0078 | 0.2857 | 1 |
Echinococcus granulosus | cpg binding protein | 0.0036 | 0.1145 | 0.365 |
Brugia malayi | Ets-domain containing protein | 0.0084 | 0.3084 | 0.3008 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0078 | 0.2857 | 1 |
Echinococcus granulosus | ETS domain containing protein Elk 1 | 0.0012 | 0.018 | 0.0492 |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.2922 | 0.284 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0072 | 0.2603 | 0.5 |
Echinococcus granulosus | tyrosyl DNA phosphodiesterase 1 | 0.0078 | 0.2857 | 0.9255 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0072 | 0.2603 | 0.258 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0059 | 0.2078 | 0.6704 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0037 | 0.1185 | 0.378 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0117 | 0.4419 | 0.4358 |
Loa Loa (eye worm) | D-ets-4 DNA binding domain-containing protein | 0.0084 | 0.3084 | 0.3004 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.1185 | 0.1158 |
Echinococcus multilocularis | cpg binding protein | 0.0036 | 0.1145 | 0.365 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0037 | 0.1185 | 0.1088 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0059 | 0.2078 | 0.6078 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0059 | 0.2078 | 0.6704 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.1185 | 0.1083 |
Schistosoma mansoni | ets-related | 0.0012 | 0.018 | 0.0151 |
Echinococcus multilocularis | ewsr:fli fusion protein type | 0.0012 | 0.018 | 0.0492 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.008 | 0.2922 | 0.2844 |
Entamoeba histolytica | tyrosyl-DNA phosphodiesterase, putative | 0.0078 | 0.2857 | 0.5 |
Echinococcus granulosus | ewsr:fli fusion protein type | 0.0012 | 0.018 | 0.0492 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0029 | 0.087 | 0.5 |
Echinococcus multilocularis | tyrosyl DNA phosphodiesterase 1 | 0.0078 | 0.2857 | 0.9255 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.018 | 0.0067 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0059 | 0.2078 | 0.5 |
Trypanosoma brucei | protein kinase, putative | 0.0059 | 0.2078 | 0.6078 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0072 | 0.2603 | 0.5 |
Echinococcus granulosus | protein C ets 2 | 0.0012 | 0.018 | 0.0492 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0114 | 0.0275 |
Echinococcus granulosus | transcription factor Dp 1 | 0.0045 | 0.1522 | 0.4885 |
Brugia malayi | MAP kinase sur-1 | 0.0059 | 0.2078 | 0.1991 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.087 | 0.0764 |
Schistosoma mansoni | cpg binding protein | 0.0034 | 0.1066 | 0.1039 |
Echinococcus granulosus | GPCR family 2 | 0.0037 | 0.1185 | 0.378 |
Onchocerca volvulus | 0.0034 | 0.1066 | 0.5 | |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0072 | 0.2603 | 0.258 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0072 | 0.2603 | 0.8423 |
Schistosoma mansoni | hypothetical protein | 0.008 | 0.2922 | 0.2901 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0059 | 0.2078 | 0.6704 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0072 | 0.2603 | 0.5 |
Schistosoma mansoni | gabp alpha | 0.0084 | 0.3084 | 0.3063 |
Schistosoma mansoni | tyrosyl-DNA phosphodiesterase | 0.0078 | 0.2857 | 0.2835 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0065 | 0.23 | 0.8252 |
Loa Loa (eye worm) | D-ets-2 protein | 0.0012 | 0.018 | 0.0067 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.